Inventor
PORRO MASSIMO
IT18 patents
⚠️ This page may combine multiple inventors who share the name “PORRO MASSIMO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOSYNTH SRL
13 patentsUS7588765B2Sep 15, 2009
Polysaccharide and glycoconjugate vaccines
BIOSYNTH SRL27 citations92
US6951652B2Oct 4, 2005
Vaccine for prevention of gram-negative bacterial infections and endotoxin related diseases
BIOSYNTH SRL21 citations92
US5652211AJul 29, 1997
Peptides for neutralizing the toxicity of Lipid A
BIOSYNTH SRL18 citations92
US5834430ANov 10, 1998
Potentiation of antibiotics
BIOSYNTH SRL18 citations86
US10300135B2May 28, 2019
Multivalent glycoconjugate vaccines
BIOSYNTH SRL12 citations83
US5589459ADec 31, 1996
Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock
BIOSYNTH SRL12 citations73
US5371186ADec 6, 1994
Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock
BIOSYNTH SRL13 citations73
US5358933AOct 25, 1994
Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock
BIOSYNTH SRL15 citations73
US11147872B2Oct 19, 2021
Multivalent glycoconjugate vaccines
BIOSYNTH SRL4 citations72
US10500263B2Dec 10, 2019
Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria
BIOSYNTH SRL4 citations72
US11576959B2Feb 14, 2023
Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria
BIOSYNTH SRL0 citations62
US11547755B2Jan 10, 2023
Multivalent glycoconjugate vaccines
BIOSYNTH SRL0 citations62
US11246919B2Feb 15, 2022
Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria
BIOSYNTH SRL0 citations62